Swiss pharma Roche is staying in lockstep with Eli Lilly, expanding its artificial intelligence offerings and Nvidia ...
Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster.
In a letter to European patients, Roche said its decision to end development of “emugrobart” was based on the drug “not consistently” improving muscle growth and motor function in a key study.
Roche now operates over 3,500 Nvidia Blackwell GPUs for AI-driven drug discovery, making it the pharma industry's largest ...
Roche Holding AG expands Nvidia AI GPUs for drug R&D, tops peers with 3,500+ Blackwell chips, see value vs Eli Lilly and ...
Roche has ramped up its investment in NVIDIA's AI chips, launching an upscaled hybrid-cloud AI factory that it believes is ...
At NVIDIA GTC, Roche announced plans to deploy large-scale AI infrastructure powered by NVIDIA to accelerate drug discovery, diagnostics and manufacturing innovation ...
By Michele Gershberg and Michael Erman PHILADELPHIA, March 16 (Reuters) - The CEO of Roche's Genentech unit, Ashley Magargee, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results